Cervavac: India's Indigenous HPV Vaccine Rollout
The government has launched a nationwide immunization drive using 'Cervavac', India's first indigenous HPV vaccine to prevent cervical cancer.
2-Minute Summary (TL;DR)
- Cervavac is India's first indigenous quadrivalent HPV vaccine, developed by Serum Institute of India (SII).
- It is integrated into the Universal Immunization Programme (UIP) to prevent cervical cancer.
- The vaccine targets adolescent girls aged 9 to 14 years.
- Cervavac aims to significantly reduce the cost of HPV vaccination compared to imported alternatives.
- Cervical cancer is the second most common cancer among women in India.
- The rollout aligns with the 'Atmanirbhar Bharat' initiative for self-reliance in healthcare.
- The vaccine protects against the four most common HPV strains (6, 11, 16, 18) responsible for most cervical cancers.
- Delivery will be through schools and government health centers to maximize accessibility.
How This Topic is Tested in Competitive Exams
| Exam | Frequency | Approx. Marks | What Gets Asked |
|---|---|---|---|
| SSC (CGL / CHSL / MTS) | High | 4–8 | Basic science, space missions, ISRO launches, and defence technology are standard SSC GK topics. |
| UPSC / State PCS | Medium | 5–8 | UPSC tests Science & Technology through governance: space policy, biotech regulations, cyber security. |
| State PCS / PSC | Medium | 3–5 | Space missions, defence acquisitions, and health research appear regularly. |
| Railway (RRB NTPC / Group D) | Very High | 6–10 | Science and Technology is one of the largest GK sections in Railway papers. |
Key Facts to Remember: Cervavac: India's Indigenous HPV Vaccine Rollout
- Cervavac is India's first indigenous quadrivalent HPV vaccine, developed by Serum Institute of India (SII).
- It is integrated into the Universal Immunization Programme (UIP) to prevent cervical cancer.
- The vaccine targets adolescent girls aged 9 to 14 years.
- Cervavac aims to significantly reduce the cost of HPV vaccination compared to imported alternatives.
- Cervical cancer is the second most common cancer among women in India.
- The rollout aligns with the 'Atmanirbhar Bharat' initiative for self-reliance in healthcare.
- The vaccine protects against the four most common HPV strains (6, 11, 16, 18) responsible for most cervical cancers.
- Delivery will be through schools and government health centers to maximize accessibility.
Practice Questions
Q1. What is the primary purpose of the indigenously developed vaccine 'Cervavac'?
- To prevent Hepatitis B
- To prevent cervical cancer
- To combat tuberculosis
- To provide immunity against dengue
Explanation: Cervavac is a Human Papillomavirus (HPV) vaccine specifically designed to prevent cervical cancer, which is a major health concern for women in India. It targets the HPV strains that are most commonly responsible for causing this type of cancer.
Q2. Which Indian organization is responsible for the development and manufacturing of Cervavac?
- Bharat Biotech
- Panacea Biotec
- Serum Institute of India (SII)
- Zydus Cadila
Explanation: The Serum Institute of India (SII), a leading vaccine manufacturer, has developed and produced Cervavac. This indigenous development is a significant achievement under India's 'Atmanirbhar Bharat' initiative.
Q3. What is the target age group for the Cervavac vaccination drive under the Universal Immunization Programme (UIP)?
- Children aged 5 to 10 years
- Adolescent girls aged 9 to 14 years
- Women aged 15 to 25 years
- All individuals above 18 years of age
Explanation: The vaccination drive focuses on adolescent girls aged between 9 and 14 years. This age group is targeted because the HPV vaccine is most effective when administered before potential exposure to the virus, typically before the onset of sexual activity.
Q4. Cervavac is classified as a 'quadrivalent' vaccine. What does this signify?
- It protects against four different types of cancers.
- It requires four doses for complete immunization.
- It targets four specific strains of the Human Papillomavirus (HPV).
- It was developed over a period of four years.
Explanation: The term 'quadrivalent' indicates that Cervavac is designed to protect against four specific types of the Human Papillomavirus (HPV). These are typically HPV types 6, 11, 16, and 18, which are responsible for the majority of cervical cancer cases and genital warts.
Q5. The introduction of Cervavac is a key step in which broader national initiative?
- Make in India
- Digital India
- Skill India
- Atmanirbhar Bharat
Explanation: Cervavac's development and rollout are strongly aligned with the 'Atmanirbhar Bharat' (self-reliant India) initiative. This program aims to boost domestic manufacturing capabilities and reduce India's dependence on imported goods, including essential medicines and vaccines.
How to Prepare Science & Technology for Government Exams — Cervavac: India's Indigenous HPV Vaccine Rollout
For Railway exams, make flashcards for every major ISRO launch — name, payload, purpose, date. These repeat frequently.
For SSC, focus on defence acquisitions and their strategic significance rather than technical specs.
For UPSC, connect every scientific development to policy — climate targets, digital India, health policy.
Related Current Affairs
Test Your Knowledge on Today's Current Affairs
10 questions · 10 minutes · Based on today's GK updates. See how prepared you really are.
Start Daily Quiz